Exact Mass: 520.2645
Exact Mass Matches: 520.2645
Found 500 metabolites which its exact mass value is equals to given mass value 520.2645
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
7beta-hydroxytaxusin
A taxane diterpenoid that is taxusin in which the hydrogen at the 7beta position is replaced by a hydroxy group.
Dolichol diphosphate
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside]
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside] is a constituent of quince (Cydonia vulgaris) leaves
Withaperuvin D
Withaperuvin D is found in fruits. Withaperuvin D is a constituent of leaves of Physalis peruviana (Cape gooseberry) Constituent of leaves of Physalis peruviana (Cape gooseberry). Withaperuvin D is found in fruits.
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside]
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is a constituent of Cydonia vulgaris (quince). Constituent of Cydonia vulgaris (quince). 3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside] is found in fruits.
rac-4-Hydroxy-4-O-(beta-D-glucuronide)-all-trans-retinyl acetate
This compound belongs to the family of Diterpene Glycosides. These are diterpenes in which an isoprene unit is glycosylated.
Nastorazepide
Caseanigrescen B
A diterpenoid of the clerodane group isolated from the leaves and flowers of Casearia nigrescens. It exhibits cytotoxicity against A2780 human ovarian cancer cell line.
(6R,9R)-9-Hydroxy-4-megastigmen-3-one 9-O-??-D-glucopyranosyl-(1鈥樏傗垎6)-??-D-glucopyranoside
Withaperuvin B
neocynapanogenin C 3-O-beta-D-oleandroside|paniculatumoside B
methyl-ent-7alpha-acetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-9alpha,15alpha-dihydroxykaur-16-en-19-oate|methyl-ent-7alpha-acetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-9alpha,15alpha-dihydroxykaur-16-en-19-oate
14-Hydroxy-3beta-(O3-methyl-beta-D-fucopyranosyloxy)-14beta-pregn-5-en-11,15,20-trion|14-hydroxy-3beta-(O3-methyl-beta-D-fucopyranosyloxy)-14beta-pregn-5-ene-11,15,20-trione
5alpha,9alpha,10beta,13alpha-tetraacetoxy-11(15->1)abeotaxa-4(20),11-dien-15-ol|5alpha,9alpha,10beta,13alpha-tetraacetoxy-15-hydroxy-11(15->1)-abeo-taxa-4(20),11-diene|5??,9??,10??,13??-Tetraacetoxy-15-hydroxy-11(15鈥樏傗垎1)-abeo-taxa-4(20),11-diene
3alpha,6alpha-dihydroxymegastigman-7-en-9-one 3-O-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|3alpha,6alpha-dihydroxymegastigman-7-en-9-one-3-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
3-hydroxy-5,6-epoxy-beta-ionol-3-O-beta-apiofuranosyl-(1->6)-beta-glucopyranoside
5R,6S,7E-megastigma-3-on-7-en-9-ol 9-O-beta-D-(6-O-beta-D-xylopyranosyl)glucopyranoside|ampelopsisionoside 6-O-beta-D-xylopyranoside|platanionoside C
13-hydroxyblumenol C apiosylglucoside|4-[3-(2-O-beta-apiofuranosyl-beta-glucopyranosyloxy)-butyl]-3-(hydroxymethyl)-5,5-dimethyl-2-cyclohexen-1-one
(20S,22S,23S,24S,25S,26S)-12alpha,22,23,26,24,25-triepoxy-5alpha,6beta,12beta,17beta,26-pentahydroxyergosta-2-en-1-one|jaborosalactol 27
(1S*,2S*,5Z,7S*,8R*,9S*,10S*,11R*,12R*,17R*)-2,9-diacetoxy-12-butanoyloxy-8-hydroxybriara-5,13-dien-18-one|cavernulin A
Phe Gln Ala Arg
2alpha-hydroxytaxusin
A taxane diterpenoid that is taxusin substituted by a hydroxy group at position 2alpha.
Glaucoside A
Glaucoside A is a natural product found in Vincetoxicum amplexicaule with data available.
C24H40O12_(2R,3E)-4-[(1S,6R)-1-Hydroxy-2,2,6-trimethyl-4-oxocyclohexyl]-3-buten-2-yl 6-O-beta-D-xylopyranosyl-beta-D-glucopyranoside
C28H40O9_1(2H)-Naphthalenone, 2,7-bis(acetyloxy)-4-[(3E)-2,5-bis(acetyloxy)-3-methyl-3-penten-1-yl]octahydro-4a,8,8-trimethyl-3-methylene
Ala Phe Gln Arg
Ala Phe Arg Gln
Ala Gln Phe Arg
Ala Gln Arg Phe
Ala Arg Phe Gln
Ala Arg Gln Phe
Cys Arg Arg Ser
Cys Arg Ser Arg
Cys Ser Arg Arg
Asp Lys Lys Met
Asp Lys Met Lys
Asp Met Lys Lys
Glu Ile Pro Tyr
Glu Ile Tyr Pro
Glu Leu Pro Tyr
Glu Leu Tyr Pro
Glu Pro Ile Tyr
Glu Pro Leu Tyr
Glu Pro Tyr Ile
Glu Pro Tyr Leu
Glu Tyr Ile Pro
Glu Tyr Leu Pro
Glu Tyr Pro Ile
Glu Tyr Pro Leu
Phe Ala Gln Arg
Phe Ala Arg Gln
Phe Ile Asn Gln
Phe Ile Gln Asn
Phe Leu Asn Gln
Phe Leu Gln Asn
Phe Asn Ile Gln
Phe Asn Leu Gln
Phe Asn Gln Ile
Phe Asn Gln Leu
Phe Gln Ile Asn
Phe Gln Leu Asn
Phe Gln Asn Ile
Phe Gln Asn Leu
Phe Gln Gln Val
Phe Gln Arg Ala
Phe Gln Val Gln
Phe Arg Ala Gln
Phe Arg Gln Ala
Phe Val Gln Gln
Gly Lys Met Trp
Gly Lys Trp Met
Gly Met Lys Trp
Gly Met Trp Lys
Gly Trp Lys Met
Gly Trp Met Lys
Ile Glu Pro Tyr
Ile Glu Tyr Pro
Ile Phe Asn Gln
Ile Phe Gln Asn
Ile Asn Phe Gln
Ile Asn Gln Phe
Ile Pro Glu Tyr
Ile Pro Tyr Glu
Ile Gln Phe Asn
Ile Gln Asn Phe
Ile Tyr Glu Pro
Ile Tyr Pro Glu
Lys Asp Lys Met
Lys Asp Met Lys
Lys Gly Met Trp
Lys Gly Trp Met
Lys Lys Asp Met
Lys Lys Met Asp
Lys Met Asp Lys
Lys Met Lys Asp
Lys Met Arg Ser
Lys Met Ser Arg
Lys Asn Pro Tyr
Lys Asn Tyr Pro
Lys Pro Asn Tyr
Lys Pro Tyr Asn
Lys Arg Met Ser
Lys Arg Ser Met
Lys Ser Met Arg
Lys Ser Arg Met
Lys Ser Thr Trp
Lys Ser Trp Thr
Lys Thr Ser Trp
Lys Thr Trp Ser
Lys Trp Gly Met
Lys Trp Met Gly
Lys Trp Ser Thr
Lys Trp Thr Ser
Lys Tyr Asn Pro
Lys Tyr Pro Asn
Leu Glu Pro Tyr
Leu Glu Tyr Pro
Leu Phe Asn Gln
Leu Phe Gln Asn
Leu Asn Phe Gln
Leu Asn Gln Phe
Leu Pro Glu Tyr
Leu Pro Tyr Glu
Leu Gln Phe Asn
Leu Gln Asn Phe
Leu Tyr Glu Pro
Leu Tyr Pro Glu
Met Asp Lys Lys
Met Gly Lys Trp
Met Gly Trp Lys
Met Lys Asp Lys
Met Lys Gly Trp
Met Lys Lys Asp
Met Lys Arg Ser
Met Lys Ser Arg
Met Lys Trp Gly
Met Arg Lys Ser
Met Arg Ser Lys
Met Ser Lys Arg
Met Ser Arg Lys
Met Trp Gly Lys
Met Trp Lys Gly
Asn Phe Ile Gln
Asn Phe Leu Gln
Asn Phe Gln Ile
Asn Phe Gln Leu
Asn Ile Phe Gln
Asn Ile Gln Phe
Asn Lys Pro Tyr
Asn Lys Tyr Pro
Asn Leu Phe Gln
Asn Leu Gln Phe
Asn Pro Lys Tyr
Asn Pro Tyr Lys
Asn Gln Phe Ile
Asn Gln Phe Leu
Asn Gln Ile Phe
Asn Gln Leu Phe
Asn Tyr Lys Pro
Asn Tyr Pro Lys
Pro Glu Ile Tyr
Pro Glu Leu Tyr
Pro Glu Tyr Ile
Pro Glu Tyr Leu
Pro Ile Glu Tyr
Pro Ile Tyr Glu
Pro Lys Asn Tyr
Pro Lys Tyr Asn
Pro Leu Glu Tyr
Pro Leu Tyr Glu
Pro Asn Lys Tyr
Pro Asn Tyr Lys
Pro Tyr Glu Ile
Pro Tyr Glu Leu
Pro Tyr Ile Glu
Pro Tyr Lys Asn
Pro Tyr Leu Glu
Pro Tyr Asn Lys
Gln Ala Phe Arg
Gln Ala Arg Phe
Gln Phe Ala Arg
Gln Phe Ile Asn
Gln Phe Leu Asn
Gln Phe Asn Ile
Gln Phe Asn Leu
Gln Phe Gln Val
Gln Phe Arg Ala
Gln Phe Val Gln
Gln Ile Phe Asn
Gln Ile Asn Phe
Gln Leu Phe Asn
Gln Leu Asn Phe
Gln Asn Phe Ile
Gln Asn Phe Leu
Gln Asn Ile Phe
Gln Asn Leu Phe
Gln Gln Phe Val
Gln Gln Val Phe
Gln Arg Ala Phe
Gln Arg Phe Ala
Gln Val Phe Gln
Gln Val Gln Phe
Arg Ala Phe Gln
Arg Ala Gln Phe
Arg Cys Arg Ser
Arg Cys Ser Arg
Arg Phe Ala Gln
Arg Phe Gln Ala
Arg Lys Met Ser
Arg Lys Ser Met
Arg Met Lys Ser
Arg Met Ser Lys
Arg Gln Ala Phe
Arg Gln Phe Ala
Arg Arg Cys Ser
Arg Arg Ser Cys
Arg Ser Cys Arg
Arg Ser Lys Met
Arg Ser Met Lys
Arg Ser Arg Cys
Ser Cys Arg Arg
Ser Lys Met Arg
Ser Lys Arg Met
Ser Lys Thr Trp
Ser Lys Trp Thr
Ser Met Lys Arg
Ser Met Arg Lys
Ser Arg Cys Arg
Ser Arg Lys Met
Ser Arg Met Lys
Ser Arg Arg Cys
Ser Thr Lys Trp
Ser Thr Trp Lys
Ser Trp Lys Thr
Ser Trp Thr Lys
Thr Lys Ser Trp
Thr Lys Trp Ser
Thr Ser Lys Trp
Thr Ser Trp Lys
Thr Trp Lys Ser
Thr Trp Ser Lys
Val Phe Gln Gln
Val Gln Phe Gln
Val Gln Gln Phe
Trp Gly Lys Met
Trp Lys Ser Thr
Trp Lys Thr Ser
Trp Ser Lys Thr
Trp Ser Thr Lys
Trp Thr Lys Ser
Trp Thr Ser Lys
Tyr Glu Ile Pro
Tyr Glu Leu Pro
Tyr Glu Pro Ile
Tyr Glu Pro Leu
Tyr Ile Glu Pro
Tyr Ile Pro Glu
Tyr Lys Asn Pro
Tyr Lys Pro Asn
Tyr Leu Glu Pro
Tyr Leu Pro Glu
Tyr Asn Lys Pro
Tyr Asn Pro Lys
Tyr Pro Glu Ile
Tyr Pro Glu Leu
Tyr Pro Ile Glu
Tyr Pro Lys Asn
Tyr Pro Leu Glu
Tyr Pro Asn Lys
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2 / 26,26,26,27,27,27-hexafluoro-25-hydroxyergocalciferol
25-Hydroxyvitamin D3-bromoacetate
7,8-Dihydrovomifoliol 9-[apiosyl-(1->6)-glucoside]
Withaperuvin D
3b,6a-Dihydroxy-alpha-ionol 9-[apiosyl-(1->6)-glucoside]
Withaperuvin
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2
26,26,26,27,27,27-hexafluoro-25-hydroxyvitamin D2
25-Hydroxyvitamin D3-bromoacetate
Gallopamil hydrochloride
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Nastorazepide
Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity. Target:CCK-2 in vitro: Z-360 binds to the gastrin/CCK-2 receptor, thereby preventing receptor activation by gastrin, a peptide hormone frequently associated with the proliferation of gastrointestinal and pancreatic tumor cells. Check for active clinical trials or closed clinical trials using this agent. in vivo: Z-360 is a novel orally active CCK-2/gastrin receptor antagonist, significantly inhibits the growth of subcutaneous xenografts of human pancreatic tumor cells in mice, and that Z-360 combined with gemcitabine prolonged survival in a pancreatic carcinoma orthotopic xenograft mice.
(4Z,7Z,9E,11E,13R,14S,16Z,19Z)-13-[(2R)-2-amino-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-14-hydroxydocosa-4,7,9,11,16,19-hexaenoic acid
Nastorazepide
7beta-Hydroxytaxa-4(20),11-diene-5alpha,9alpha,10beta,13alpha-tetrayl tetraacetate
5-(2-amino-1-hydroxyethyl)-2-[[(2R,3R,4S,5R,6R)-5-carbamoyloxy-3-(3,6-diaminohexanoylamino)-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-4,5-dihydro-1H-imidazole-4-carboxylic acid
(2-Methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1-biphenyl]-4-yl)(1-methyl-6,7-dihydrospiro[furo[2,3-f]indole-3,4-piperidin]-5(2H)-yl)methanone
2-Hydroxy-2alpha,5alpha,9alpha,10beta,13alpha-taxa-4(20),11-diene-5,9,10,13-tetrayl tetraacetate
S-[(3Z,6R,7S,15Z,18Z)-21-carboxy-6-hydroxyhenicosa-3,8,10,12,15,18-hexaen-7-yl]-L-cysteinylglycine
3-[(3aS,10bS)-2-[4-(3-hydroxypropoxy)phenyl]-4-oxo-5-prop-2-enyl-6,10b-dihydrooxazolo[4,5-d][2]benzazepin-3a-yl]propanoic acid tert-butyl ester
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
N-[[(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-(3-pyridinyl)acetamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[(5-phenyl-3-isoxazolyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
3-(3,5-dimethyl-1,2-oxazol-4-yl)-1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methylurea
methyl 6-{[4,6-dideoxy-3-O-(4,6-dideoxy-4-formamido-2,3-di-O-methyl-alpha-D-mannopyranosyl)-4-formamido-alpha-D-mannopyranosyl]oxy}hexanoate
(3S,6S)-3,4,5-trihydroxy-6-[[(1S,2S,10S,13R,14S,17S,18S)-17-hydroxy-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-5-yl]oxy]oxane-2-carboxylic acid
(4S,5S)-5-[(1R)-2-amino-1-hydroxyethyl]-2-[[(2R,3R,4S,5R,6R)-5-carbamoyloxy-3-[[(3S)-3,6-diaminohexanoyl]amino]-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]amino]-4,5-dihydro-1H-imidazole-4-carboxylic acid
(1Z,4S,12R,14S,17Z)-12-hydroxy-19,19-dimethyl-7-(3-methylbut-2-enyl)-3,5,16,21-tetrazaheptacyclo[14.13.0.03,14.04,12.06,11.020,28.022,27]nonacosa-1(29),6,8,10,17,20(28),22,24,26-nonaene-2,15-dione
(1Z,4R,5S,14S,16S,19Z)-14-hydroxy-5,6,6,21,21-pentamethyl-3,7,18,23-tetrazaoctacyclo[16.13.0.03,16.04,7.04,14.08,13.022,30.024,29]hentriaconta-1(31),8,10,12,19,22(30),24,26,28-nonaene-2,17-dione
rac-4-Hydroxy-4-O-(beta-D-glucuronide)-all-trans-retinyl acetate
(13R)-S-cysteinylglycinyl-(14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid
A docosanoid that is (14S)-hydroxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid in which a cysteinylglycinyl group is attached at position 13R via a sulfide linkage.
16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid
A docosanoid that is 17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid in which a cysteinylglycinyl group is attached at position 16S via a sulfide linkage. An intermediate of specialized proresolving mediators
SB 224289
A member of the class of benzamides obtained by formal condensation of the carboxy group of 2-methyl-4-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-carboxylic acid with the secondary amino group of 1-methyl-6,7-dihydro-5H-spiro[furo[2,3-f]indole-3,4-piperidine]. Selective 5-HT1B receptor antagonist (pKi = 8.2). Displays >60-fold selectivity over 5-HT1D, 5-HT1A, 5-HT1E, 5-HT1F, 5-HT2A and 5-HT2C receptors in radioligand binding and functional assays. Centrally active following oral administration in vivo.
12-hydroxy-8-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one
(1s,2r,7s,8z,12r,13s,14s,16r,17r)-2,14-bis(acetyloxy)-16-hydroxy-4,9,13,17-tetramethyl-5-oxo-6-oxatricyclo[11.4.0.0³,⁷]heptadeca-3,8-dien-12-yl butanoate
7-hydroxy-8-[(5-hydroxy-4-methoxy-6-methyloxan-2-yl)oxy]-5,19-dimethyl-15,18,20-trioxapentacyclo[14.5.1.0⁴,¹³.0⁵,¹⁰.0¹⁹,²²]docosa-1(21),10-dien-14-one
(1s,3r,5r,6as,7r,8s,9r,10r,10ar)-1,3-bis(acetyloxy)-9,10-dihydroxy-7,8-dimethyl-7-(3-methylidenepent-4-en-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-5-yl butanoate
(4s)-5,5-dimethyl-4-[(3r)-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}butyl]cyclohex-2-en-1-one
4-(4-{[6-({[3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-1-hydroxy-2,2,6-trimethylcyclohexyl)but-3-en-2-one
(1z,4s,12r,14r,17z)-12-hydroxy-19,19-dimethyl-5-(3-methylbut-2-en-1-yl)-3,5,16,21-tetraazaheptacyclo[14.13.0.0³,¹⁴.0⁴,¹².0⁶,¹¹.0²⁰,²⁸.0²²,²⁷]nonacosa-1(29),6,8,10,17,20(28),22,24,26-nonaene-2,15-dione
6-(1-{1,3a,5,5a,6-pentahydroxy-9a,11a-dimethyl-9-oxo-2h,3h,3bh,4h,5h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-hydroxyethyl)-3,4-dimethyl-5,6-dihydropyran-2-one
(1s,2r,5r,10r,11r,14r,16s,17r,20s,21s,22r)-11,16,21-trihydroxy-8-isopropyl-14-methoxy-2,5-dimethyl-15,19,23-trioxahexacyclo[18.2.1.0²,¹⁰.0⁵,⁹.0¹³,²².0¹⁶,²¹]tricosa-8,12-dien-17-yl acetate
14beta-hydroxytaxusin
{"Ingredient_id": "HBIN001389","Ingredient_name": "14beta-hydroxytaxusin","Alias": "14\u03b2-hydroxytaxusin","Ingredient_formula": "C28H40O9","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C(=C)C3CC(C2(C)C)C(C1OC(=O)C)O)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "520.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "31276;10739","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "5318353","DrugBank_id": "NA"}
2-deacetoxy-5-decinnamoyl taxinine j
{"Ingredient_id": "HBIN005491","Ingredient_name": "2-deacetoxy-5-decinnamoyl taxinine j","Alias": "NA","Ingredient_formula": "C28H40O9","Ingredient_Smile": "CC1=C2C(C(C3(C(CC(C2(C)C)CC1OC(=O)C)C(=C)C(CC3OC(=O)C)O)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4703","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2-deacetoxy-5-decinnamoyl taxinin j
{"Ingredient_id": "HBIN005492","Ingredient_name": "2-deacetoxy-5-decinnamoyl taxinin j","Alias": "NA","Ingredient_formula": "C28H40O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "26041","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5α,9α,10β,13α-tetraacetoxy-15-hydroxy-11(15→1)-abeo-taxa-4(20),11-diene
{"Ingredient_id": "HBIN011397","Ingredient_name": "5\u03b1,9\u03b1,10\u03b2,13\u03b1-tetraacetoxy-15-hydroxy-11(15\u21921)-abeo-taxa-4(20),11-diene","Alias": "NA","Ingredient_formula": "C28H40O9","Ingredient_Smile": "CC1=C2C(C(C3(CCC(C(=C)C3CC2(CC1OC(=O)C)C(C)(C)O)OC(=O)C)C)OC(=O)C)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21012","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(6r,9r)-9-hydroxy-4-megastigmen-3-one 9-o-β-d-glucopyranosyl-(1→6)-β-d-glucopyrano-side
{"Ingredient_id": "HBIN012787","Ingredient_name": "(6r,9r)-9-hydroxy-4-megastigmen-3-one 9-o-\u03b2-d-glucopyranosyl-(1\u21926)-\u03b2-d-glucopyrano-side","Alias": "NA","Ingredient_formula": "C24H40O12","Ingredient_Smile": "CC(CCC1C=CC(=O)CC1(C)C)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10373","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7β-hydroxy-2α,5α,10β,14β-tetraacetoxytaxa-4(20),11-diene
{"Ingredient_id": "HBIN013103","Ingredient_name": "7\u03b2-hydroxy-2\u03b1,5\u03b1,10\u03b2,14\u03b2-tetraacetoxytaxa-4(20),11-diene","Alias": "NA","Ingredient_formula": "C28H40O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10742","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
adenanthin d
{"Ingredient_id": "HBIN014675","Ingredient_name": "adenanthin d","Alias": "NA","Ingredient_formula": "C28H40O9","Ingredient_Smile": "CC(=O)OC1CC2CC3(C1C4(C(CC3OC(=O)C)C(C(CC4OC(=O)C)O)(C)C)C)C(C2=C)OC(=O)C","Ingredient_weight": "520.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "608","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11060386","DrugBank_id": "NA"}